NYSE:RMDMedical Equipment
ResMed At Wearable And AI Turning Point In Sleep Apnea Care
ResMed (NYSE:RMD) is at an inflection point as wearable devices move into mainstream use for sleep apnea screening.
Recent FDA approvals support broader adoption of sleep and respiratory care technologies across the sector.
New AI-enabled products and digital health ecosystem updates are intended to deepen patient engagement and data integration.
Legacy competitor setbacks and ResMed's digital offerings may influence how market share develops from here.
ResMed, listed on the NYSE under...